# Diane Damotte

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/diane-damotte/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,490 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 72 |
| i10-index | 177 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5075646456 |
| ORCID iD | https://orcid.org/0000-0001-5355-3045 |
| Works | 610 |

## Researcher papers

- [Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II](https://scholariq.org/papers/presentation-and-long-term-follow-up-of-refractory-celiac-disease-comparison-of/)
- [<i>TP53, STK11</i> , and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma](https://scholariq.org/papers/i-tp53-stk11-i-and-i-egfr-i-mutations-predict-tumor-immune-profile-and-the/)
- [Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer](https://scholariq.org/papers/cisplatin-increases-pd-l1-expression-and-optimizes-immune-check-point-blockade/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.